In the progression of melanoma, recent evidence support that the metastatic malignant melanocytes down-regulate P-cadherin expression and acquire a migratory phenotype as the result of SLUG expression, a melanocyte lineage transcription factor that was shown to downregulate this junctional protein. The gene discussed is CDH3; the disease is melanoma.